Weight Loss News and Research

Latest Weight Loss News and Research

Mirafit fbcx reduces human body absorption of consumed fat

A scientific study to be presented today at the annual meeting of The Obesity Society will confirm significant weight loss using the pill mirafit fbcx®. Dr. K-L Catherine Jen and Dr. Joseph Artiss, principals at ArtJen Complexus USA, LLC, will present these clinical study findings today, October 27, at The Obesity Society 2009 annual scientific meeting at the Marriott Wardman Park Hotel in Washington, D.C., The Obesity Society's 27th annual scientific meeting.

28 Oct 2009

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which support the safety and efficacy of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus.

27 Oct 2009

Hope for lung cancer patients

Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year. It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.

27 Oct 2009

Want to shed more weight? Enroll a family member or friend

Enrolling in a weight loss program with a family member or friend appears to enhance weight loss among African Americans, but only if the involved partner attends sessions frequently or also loses weight, according to a report in the October 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Oct 2009

Detecting the cause of occult gastrointestinal bleeding with the PillCam SB video capsule demonstrated

Given Imaging Ltd. today announced that new data presented at the American College of Gastroenterology (ACG) 2009 Conference show that by visualizing the small bowel with the PillCam® SB video capsule, physicians can detect the cause of occult gastrointestinal bleeding (OGIB) and adapt how they manage and treat these patients.

27 Oct 2009

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Solvay Pharmaceuticals, Inc. announced that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in adults with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatic surgery.

27 Oct 2009

Cardio Infrared Technologies to deliver new Cardio-Cor II unit to Utah and Florida

Cardio Infrared Technologies, Inc. (PINKSHEETS: CDOI) www.cardio-cor.com, a leading Health and Wellness technology and marketing company, announced today that orders and commitments for new orders are being received by the company on the Cardio-Cor II™. Doctors weight loss clinics in Florida and Utah have either placed orders or have committed to the purchase the Cardio-Cor II. Inquires on the Cardio-Cor II have been incredibly high and constant since the press release on the new unit.

27 Oct 2009

DVD series "Start Fitness Now: Beating Type 2 Diabetes" released

NBC's "Biggest Loser" trainer Kim Lyons announces the newest addition to her fitness empire- 3 title DVD series Start Fitness Now: Beating Type 2 Diabetes and online support forum; produced and distributed by Watch It Now Entertainment.

26 Oct 2009

AlterG M300 anti-gravity treadmill for physical therapy clinics, fitness and training facilities

AlterG, Inc., makers of the Anti-Gravity Treadmill, a revolutionary technology for rehabilitation and athletic training, today launched the AlterG M300. The M300 delivers the same anti-gravity technology originally developed at NASA and found in AlterG's P200 series, only at a third of the price and with a sleek new design.

26 Oct 2009

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.

26 Oct 2009

Smart for Life Cookie Diet program helps people to keep weight off

Brooke Webb Masten, featured in Smart for Life broadcast advertising, has maintained her 105-pound weight loss and reached her 3-year milestone. She continues her success by eating Smart for Life cookies, shakes, soups and muffins as well as an exercise routine.

24 Oct 2009

Nutripure Beverages to expand its distribution network

NutriPure Beverages, Inc. and its subsidiary XND Technologies, Inc. announced today that they are in final negotiations with a Southern California-based distributor located in Santa Ana.

24 Oct 2009

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in an international Phase 3 trial to evaluate Nexavar® (sorafenib) tablets for the treatment of patients with radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer.

23 Oct 2009

Community based initiative to help combat obesity and promote healthy lifestyles

President Bill Clinton made a special appearance on October 10 to open the Weight Watchers Presents Fun and Fit in the City -- at the Harlem Children's Zone in Harlem, NY. Part of the Food Network New York City Wine & Food Festival, the free community based initiative -- which drew over 800 attendees -- was created to help combat obesity and provide practical tips for families to follow healthier lifestyles.

23 Oct 2009

Physicians' negative attitudes toward obese patients can affect quality of care

Doctors have less respect for their obese patients than they do for patients of normal weight, a new study by Johns Hopkins researchers suggests. The findings raise questions about whether negative physician attitudes about obesity could be affecting the long-term health of their heavier patients.

23 Oct 2009

American Thoracic Society releases new clinical guidelines for pulmonary exacerbation of cystic fibrosis

The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices.

23 Oct 2009

AAFP receives MetLife Foundation grant to counter childhood obesity

The American Academy of Family Physicians (AAFP) and the AAFP Foundation announce that they have been awarded a $150,000 grant from MetLife Foundation, designed to counter the national epidemic of childhood obesity by empowering family physicians with new ways to promote physical activity, nutrition and emotional well-being. The partnership will produce educational materials for children, including books and publications.

23 Oct 2009

KemPharm commences KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm’s proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.

22 Oct 2009

Anabolic steroid cycles available from Online Legal Steroids

Online Legal Steroids, a leading online supplier of muscle enhancers, bodybuilding supplements and legal steroids products, now offers legal steroid cycles for any and every customer, regardless of what their goals entail.

22 Oct 2009

First clinical trial to test a weight maintenance program for obese pregnant women

More than half of women in the United States are overweight or obese when they become pregnant, and most go on to gain more than the recommended amount during pregnancy. The excess weight can lead to a myriad of complications, including preeclampsia, diabetes, bigger babies, C-sections, birth injuries, and weight retention after pregnancy.

22 Oct 2009

Weight Loss News and Research

Latest Weight Loss News and Research

Mirafit fbcx reduces human body absorption of consumed fat

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

Hope for lung cancer patients

Want to shed more weight? Enroll a family member or friend

Detecting the cause of occult gastrointestinal bleeding with the PillCam SB video capsule demonstrated

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Cardio Infrared Technologies to deliver new Cardio-Cor II unit to Utah and Florida

DVD series "Start Fitness Now: Beating Type 2 Diabetes" released

AlterG M300 anti-gravity treadmill for physical therapy clinics, fitness and training facilities

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Smart for Life Cookie Diet program helps people to keep weight off

Nutripure Beverages to expand its distribution network

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals start Phase 3 trial to evaluate Nexavar tablets

Community based initiative to help combat obesity and promote healthy lifestyles

Physicians' negative attitudes toward obese patients can affect quality of care

American Thoracic Society releases new clinical guidelines for pulmonary exacerbation of cystic fibrosis

AAFP receives MetLife Foundation grant to counter childhood obesity

KemPharm commences KP106 Phase 1 clinical trial for ADHD

Anabolic steroid cycles available from Online Legal Steroids

First clinical trial to test a weight maintenance program for obese pregnant women

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Weight Loss News and Research

Latest Weight Loss News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in